- \n\t\t\t\t\t\t\t
- \n\t\t\t\t\t\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t\t\t\t\tHome<\/span>\n\t\t\t\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t
- \n\t\t\t\t\t\t\t\t\t\tProducts<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t
- \n\t\t\t\t\t\t\t\t\t\tSoftware<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t
- \n\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t<\/ul>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\tSaaS Software<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t \n\t\t\t\t\t\n\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\n\t\t\t\t\tIQ-UIP\u2122\n<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\n\t\t\t\t\tA New Approach to UIP\nIdentification for IPF\nManagement<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\t\t\t\t\tFDA \u201cBreakthrough Device\u201d\u2013Advancing EarlyDetection and Intervention<\/i><\/h5>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\n\n\n\n\n\n\nIQ-UIP\u2122 is state-of-the-art software powered by deep learning, designed to accurately classify Usual Interstitial Pneumonia (UIP) and predict patient survival directly from inspiratory CT scans. Achieving expert-level performance, IQ-UIP matches the accuracy of seasoned CT readers and was FDA-cleared in 2024, establishing a new standard for pulmonary diagnostics.<\/p>\n
FDA 510(k) Cleared, For Investigational Use Only outside of the United States<\/em><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t \n\t\t\t\t\t\n\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\n\t\t\t\t\tThe Challenge: Timely, Accurate UIP Detection<\/span><\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t- \n
- \n
Delayed Diagnosis: <\/strong>UIP, most frequently associated with idiopathic pulmonary fibrosis (IPF), is notoriously difficult to detect. On average, patients consult three or more physicians, undergo multiple CT scans1<\/sup>, <\/span>and wait up to two years for a definitive diagnosis <\/span>losing p<\/span>recious time for treatment.<\/span><\/p>\n<\/li>\n
- Poor Prognosis: <\/strong>After diagnosis, expected survival is only 3\u20135 years2<\/sup>, further reduced by diagnostic delays. Early, accurate detection is essential to meaningfully extend patients\u2019 lives.<\/li>\n
- <\/li>\n
- Diagnostic Overlap: <\/strong> IPF symptoms are often mistaken for other lung diseases such as COPD or asthma\u2014contributing to a misdiagnosis rate exceeding 50%.3<\/sup><\/li>\n<\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t \n\t\t\t\t\t\n\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\n\t\t\t\t\tThe IQ-UIP Solution: Powerful, AI Proactive Care<\/span><\/span><\/span><\/div><\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\t\t\t\t\tIQ-UIP harnesses advanced AI to automatically scan chest CTs, reliably identifying UIP patterns and flagging patients for timely specialist referral. This approach enables:<\/p>
\u00a0<\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t![\"\"](\"https:\/\/4dmedical.com\/us\/wp-content\/uploads\/sites\/2\/2025\/05\/IQ-UIP-Report-English.png\")
\t\t\t\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t - Poor Prognosis: <\/strong>After diagnosis, expected survival is only 3\u20135 years2<\/sup>, further reduced by diagnostic delays. Early, accurate detection is essential to meaningfully extend patients\u2019 lives.<\/li>\n
- \n\t\t\t\t\t\t\t\t\t\tProducts<\/span>\n\t\t\t\t\t\t\t\t\t<\/li>\n\t\t\t\t\t\t\t\t